Naltrexone for the management of post-burn pruritus: A preliminary report

Burns

Volumn 34, Issue 6, 2008, Pages 797-802

  LaSalle, L ^a   Rachelska, G ^a,b   Nedelec, B ^a,b,c  

^a Hopital de Readaptation Villa Medica   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Burn injury; Naltrexone; Pruritus

Indexed keywords

NALTREXONE;

ADULT; ANXIETY; ARTICLE; BURN; BURN PATIENT; CASE STUDY; CLINICAL ARTICLE; DISEASE DURATION; DIZZINESS; DRUG WITHDRAWAL; EATING; EXERCISE; FATIGUE; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRURITUS; QUALITY OF LIFE; SIDE EFFECT; SLEEP DISORDER; SWEATING; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 47649099909     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2007.10.009     Document Type: Article

References (16)

1. Nelson R.D. Postburn itch. In: Yosipovitch G., Greaves M.W., Fleischer A.B., and McGlone F. (Eds). Itch: basic mechanisms and therapy (2004), Marcel Dekker, Inc., New York 247-254
2. Malenfant A., Forget R., Papillon J., Amsel R., Frigon J.Y., and Choiniere M. Prevalence and characteristics of chronic sensory problems in burn patients. Pain 67 2-3 (1996) 493-500
3. Wolfhagen F.H., Sternieri E., Hop W.C., Vitale G., Bertolotti M., and Van Buuren H.R. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 113 4 (1997) 1264-1269
4. Bergasa N.V., Talbot T.L., Alling D.W., Schmitt J.M., Walker E.C., Baker B.L., et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 102 2 (1992) 544-549
5. Bergasa N.V., Alling D.W., Talbot T.L., Swain M.G., Yurdaydin C., Turner M.L., et al. Effects of naloxone infusions in patients with the pruritus of cholestasis A double-blind, randomized, controlled trial. Ann Intern Med 123 3 (1995) 161-167
6. Terg R., Coronel E., Sorda J., Munoz A.E., and Findor J. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study. J Hepatol 37 6 (2002) 717-722
7. Bergasa N.V., Alling D.W., Talbot T.L., Wells M.C., and Jones E.A. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol 41 3 Pt 1 (1999) 431-434
8. Peer G., Kivity S., Agami O., Fireman E., Silverberg D., Blum M., et al. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 348 9041 (1996) 1552-1554
9. Metze D., Reimann S., Beissert S., and Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 41 4 (1999) 533-539
10. Ajayi A.A., Kolawole B.A., and Udoh S.J. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching. Int J Dermatol 43 12 (2004) 972-977
11. Bergasa N.V. The pruritus of cholestasis. J Hepatol 43 6 (2005) 1078-1088
12. Faucher L., and Furukawa K. Practice guidelines for the management of pain. J Burn Care Res 27 5 (2006) 659-668
13. Omoigui S. Pain Drugs Handbook. 2nd ed. (1999), Blackwell Science Inc., Malden, Massachusetts pp. 426-429
14. Bell L., McAdams T., Morgan R., Parshley P.F., Pike R.C., Riggs P., et al. Pruritus in burns: a descriptive study. J Burn Care Rehabil 9 3 (1988) 305-308
15. Parent-Vachon M., Parnell L.K.S., Rachelska G., LaSalle L., and Nedelec B. Cross-cultural adaptation and validation of the Questionnaire for Pruritus Assessment for use in the French Canadian burn survivor population. Burns 34 1 (2008) 71-92
16. Molenaar H.A., Oosting J., and Jones E.A. Improved device for measuring scratching activity in patients with pruritus. Med Biol Eng Comput 36 2 (1998) 220-224